Literature DB >> 6439737

A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.

D M Stern, P P Nawroth, W Kisiel, D Handley, M Drillings, J Bartos.   

Abstract

Previous studies have demonstrated the binding of Factors IX and IXa to cultured bovine aortic endothelial cells. The present study examines the interaction of Factors IX, IXa, and Xa with the luminal surface of calf aortas, shown by microscopic examination to have a continuous layer of endothelium. Radioimmunoassay of Factor IX showed that 74 fmol/10(6) cells of Factor IX could be eluted from freshly prepared aortic segments. Binding of 3H-Factors IX and IXa to aortic segments was saturable, and comparable to binding in previous studies using cultured endothelial cells. Preincubation of aortic segments with 3H-Factor IXa and von Willebrand factor (VWF)/Factor VIII, followed by washing and addition of Factor X, resulted in formation of Factor Xa. The addition of prothrombin to these activation mixtures resulted in formation of thrombin. Exogenous phospholipid and Factor V were not required for Factor X and prothrombin activation on the intact native endothelium. Incubation of 125I-Factor Xa with the vessel segments resulted in most of the tracer being complexed with antithrombin III originally present on the aortic segment (3.8 pmol antithrombin III/10(6) cells). The Factor Xa-antithrombin III complex was observed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis exclusively in the supernatants. 125I-Factor Xa not complexed with antithrombin III bound specifically to the vessel segment. The time course of binding was biphasic, consisting of an initial more rapid reversible phase followed by a slower irreversible phase. The latter phase correlated with the formation of a covalent complex (Mr, 76,000) between 125I-Factor Xa and a vessel-localized protein presumably distinct from antithrombin III. The activation of prothrombin by vessel-bound Factor Xa was inhibited by anti-bovine Factor V IgG, suggesting that there is interaction of Factor Xa with a Factor V-like molecule provided by the endothelial cell surface. Addition of antibody to antithrombin III prevented formation of Factor Xa-antithrombin III and thrombin-antithrombin III complexes in the supernatant and increased apparent thrombin activity 30-50-fold. These studies demonstrate that freshly obtained vessels with a continuous layer of native endothelium can support activation of Factor X and prothrombin: vessel-bound Factor IXa can activate Factor X in the presence of VWF/Factor VIII. Factor Xa can also bind to the vessel and participate in the activation of prothrombin. The apparent efficiency of prothrombin activation, however, is dampened by the presence of functional antithrombin III on the vessel wall.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439737      PMCID: PMC425377          DOI: 10.1172/JCI111611

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Binding of factors IX and IXa to cultured vascular endothelial cells.

Authors:  D M Stern; M Drillings; H L Nossel; A Hurlet-Jensen; K S LaGamma; J Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

2.  The role of phospholipid and factor VIIIa in the activation of bovine factor X.

Authors:  G van Dieijen; G Tans; J Rosing; H C Hemker
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

3.  Cellular cooperation in endothelial cell thromboplastin synthesis.

Authors:  T Lyberg; K S Galdal; S A Evensen; H Prydz
Journal:  Br J Haematol       Date:  1983-01       Impact factor: 6.998

4.  Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium.

Authors:  C Busch; W G Owen
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

5.  Factor IX antigen by a rapid staphylococcal protein A-membrane binding radioimmunoassay: results in haemophilia B patients and carriers and in fetal samples.

Authors:  L A Suzuki; A R Thompson
Journal:  Br J Haematol       Date:  1982-04       Impact factor: 6.998

6.  Acquired antibody to factor XI in a patient with congenital factor XI deficiency.

Authors:  D M Stern; H L Nossel; J Owen
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

7.  Binding of human factor VII and VIIa to monocytes.

Authors:  G J Broze
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

8.  Regulation of factor Xa in vitro in human and mouse plasma and in vivo in mouse. Role of the endothelium and plasma proteinase inhibitors.

Authors:  H E Fuchs; S V Pizzo
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

9.  Bovine endothelial cells in culture produce thromboxane as well as prostacyclin.

Authors:  C Ingerman-Wojenski; M J Silver; J B Smith; E Macarak
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

10.  Binding of coagulation factors IX and X to the endothelial cell surface.

Authors:  R L Heimark; S M Schwartz
Journal:  Biochem Biophys Res Commun       Date:  1983-03-16       Impact factor: 3.575

View more
  14 in total

1.  Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.

Authors:  P P Nawroth; D A Handley; C T Esmon; D M Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

2.  Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.

Authors:  G M Rodgers; W H Kane
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

3.  An endothelial cell-dependent pathway of coagulation.

Authors:  D Stern; P Nawroth; D Handley; W Kisiel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

4.  Active site-labeled prothrombin inhibits prothrombinase in vitro and thrombosis in vivo.

Authors:  Heather K Kroh; Peter Panizzi; Svetlana Tchaikovski; T Regan Baird; Nancy Wei; Sriram Krishnaswamy; Guido Tans; Jan Rosing; Bruce Furie; Barbara C Furie; Paul E Bock
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

5.  Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties.

Authors:  S Ogawa; H Gerlach; C Esposito; A Pasagian-Macaulay; J Brett; D Stern
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

6.  Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium.

Authors:  Samit Ghosh; Usha R Pendurthi; Anne Steinoe; Charles T Esmon; L Vijaya Mohan Rao
Journal:  J Biol Chem       Date:  2007-02-27       Impact factor: 5.157

7.  Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.

Authors:  K A Bauer; T L Goodman; B L Kass; R D Rosenberg
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

8.  Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein.

Authors:  Michael J Osgood; Kyle M Hocking; Igor V Voskresensky; Fan Dong Li; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  J Vasc Surg       Date:  2013-07-30       Impact factor: 4.268

9.  Norepinephrine down-regulates the activity of protein S on endothelial cells.

Authors:  J G Brett; S F Steinberg; P G deGroot; P P Nawroth; D M Stern
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

10.  Self-regulation of procoagulant events on the endothelial cell surface.

Authors:  D M Stern; I Bank; P P Nawroth; J Cassimeris; W Kisiel; J W Fenton; C Dinarello; L Chess; E A Jaffe
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.